Keyphrases
Cancer Cell Death
100%
Breast Cancer Cells
100%
Histone Deacetylase Inhibitor (HDACi)
100%
Detection Sensor
100%
Apoptosis Assay
100%
Breast Cancer
75%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Triple-negative Breast Cancer
50%
Flow Cytometry
25%
Detection System
25%
Synergic
25%
Living Cells
25%
Sensor Detection
25%
Therapeutic Benefits
25%
Breast Tumor
25%
Malignancy
25%
Epidermal Growth Factor Receptor
25%
Breast
25%
Doxorubicin
25%
Estrogen Receptor
25%
Poor Survival
25%
Treatment Options
25%
Kinetic Analysis
25%
Cell Viability Assay
25%
Anticancer Therapy
25%
Bioluminescence
25%
Survival Rate
25%
Cancer Causes
25%
Cancer Mortality
25%
Anticancer Effect
25%
MDA-MB-231
25%
Co-treatment
25%
Apoptotic Cell Death
25%
Triple-negative Breast Cancer Cells
25%
Breast Cancer Subtypes
25%
MCF10A
25%
Progesterone Receptor
25%
Normal Epithelium
25%
Panobinostat
25%
Epithelia Cells
25%
Marker Identification
25%
Belinostat
25%
Apoptotic Markers
25%
Medicine and Dentistry
Breast Cancer
100%
Cancer Cell
100%
Programmed Cell Death
100%
Cell Death
100%
Histone
100%
Deacetylation
100%
Triple Negative Breast Cancer
50%
Epidermal Growth Factor Receptor 2
33%
Gamma Urogastrone
33%
Flow Cytometry
16%
Malignant Neoplasm
16%
Cancer
16%
Doxorubicin
16%
Survival Rate
16%
Breast Tumor
16%
Cancer Mortality
16%
Epithelium Cell
16%
Estrogen Receptor
16%
Progesterone Receptor
16%
Antiinfective Agent
16%
Cancer Treatment
16%
Panobinostat
16%
Cell Viability Assay
16%
Belinostat
16%
Bioluminescence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Histone
100%
Triple Negative Breast Cancer
50%
Malignant Neoplasm
33%
Epidermal Growth Factor Receptor 2
33%
Gamma Urogastrone
33%
Antiinfective Agent
16%
Flow Cytometry
16%
Doxorubicin
16%
Cell Viability
16%
Survival Rate
16%
Estrogen Receptor
16%
Breast Tumor
16%
Cancer Mortality
16%
Progesterone Receptor
16%
Viability Assay
16%
Panobinostat
16%
Belinostat
16%